Detection of liver fibrosis stages in patients with hepatitis C virus infection by non-invasive tool

Background S100A14 is a novel significant individual from S100 proteins family. Its significance is because of its part in tumorigenesis and metastasis process. Elevated level of S100A14 was associated with poor tumor differentiation. A relatively high dose of S100A14 was capable to induce cell inju...

Full description

Saved in:
Bibliographic Details
Published in:Egyptian Liver Journal 2021-01, Vol.11 (1), p.9-6
Main Authors: Serag, Waleed Mohamed, Elsayed, Basem Eysa
Format: Article
Language:English
Subjects:
and AAR
Apoptosis
APRI
Enzyme-linked immunosorbent assay
Extracellular matrix
Females
FIB-4
Fibrosis
Health aspects
Hepatitis C
Hepatitis C virus
Liver
Liver cirrhosis
Liver diseases
Metastasis
Proteins
S100A14
Signal transduction
Stage of fibrosis
Virus diseases
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background S100A14 is a novel significant individual from S100 proteins family. Its significance is because of its part in tumorigenesis and metastasis process. Elevated level of S100A14 was associated with poor tumor differentiation. A relatively high dose of S100A14 was capable to induce cell injuries. It was discovered that S100A14 is seen at the extracellular medium. S100A14 induces the activation of apoptotic mediators and cell apoptosis. The aim of this study is to assess the clinical response of S100A14 in the detection the stages of liver fibrosis in patients of chronic HCV. ELISA was used to detect the levels of serum S100A14 in both different stages of fibrosis of the liver and control groups, and then, they were noticed together with the results of fibroscan. Other noninvasive markers of fibrosis were calculated such as APRI, AAR, and FIB-4 score. Results Protein expression level of S100A14 was positive correlated significantly with stages of fibrosis. Conclusion Measurement of serum level of S100A14 is a useful non-invasive marker for detection of the stages of liver fibrosis in patients of chronic HCV. Combinations of measuring S100A14 level to FIB-4 or S100A14 to APRI give a sensitive tool for diagnosing significant fibrosis.
ISSN:2090-6218
2090-6226
DOI:10.1186/s43066-021-00076-w